Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Endonovo Therapeutics (ENDV) Amortizatization of Intangibles (2018 - 2023)

Endonovo Therapeutics has reported Amortizatization of Intangibles over the past 8 years, most recently at $161728.0 for Q1 2023.

  • Quarterly results put Amortizatization of Intangibles at $161728.0 for Q1 2023, changed 0.0% from a year ago — trailing twelve months through Mar 2023 was $110611.0 (down 58.09% YoY), and the annual figure for FY2022 was $110611.0, down 23.29%.
  • Amortizatization of Intangibles for Q1 2023 was $161728.0 at Endonovo Therapeutics, up from $20184.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for ENDV hit a ceiling of $671929.0 in Q1 2019 and a floor of -$102590.0 in Q2 2022.
  • Median Amortizatization of Intangibles over the past 5 years was $40537.0 (2021), compared with a mean of $158038.0.
  • Peak annual rise in Amortizatization of Intangibles hit 285.07% in 2022, while the deepest fall reached 433.62% in 2022.
  • Endonovo Therapeutics' Amortizatization of Intangibles stood at $307226.0 in 2019, then crashed by 43.1% to $174823.0 in 2020, then tumbled by 76.81% to $40537.0 in 2021, then crashed by 50.21% to $20184.0 in 2022, then surged by 701.27% to $161728.0 in 2023.
  • The last three reported values for Amortizatization of Intangibles were $161728.0 (Q1 2023), $20184.0 (Q4 2022), and $31289.0 (Q3 2022) per Business Quant data.